LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 53.50 | 21.74 | 5358 | 5425 | 0.9875 | 0.9968 | MN20160310_N01 | M03 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 55.48 | 21.74 | 18 | 5768 | 0.0031 | -0.0232 | MN20160310_N01 | I15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 55.48 | 21.74 | 7497 | 5768 | 1.2996 | 1.0662 | MN20160310_N01 | I15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 55.48 | 21.74 | 2261 | 5768 | 0.3919 | 0.7804 | MN20160310_N01 | M03 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 55.48 | 21.74 | 5694 | 5768 | 0.9870 | 0.9968 | MN20160310_N01 | M03 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 57.45 | 21.74 | 23 | 6023 | 0.0038 | 0.0070 | MN20160310_N01 | I15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 57.45 | 21.74 | 7933 | 6023 | 1.3170 | 1.0690 | MN20160310_N01 | I15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 57.45 | 21.74 | 2170 | 6023 | 0.3603 | 0.7635 | MN20160310_N01 | M03 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 57.45 | 21.74 | 6041 | 6023 | 1.0029 | 1.0007 | MN20160310_N01 | M03 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 59.42 | 21.74 | 33 | 6125 | 0.0054 | 0.0526 | MN20160310_N01 | I15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 59.42 | 21.74 | 8331 | 6125 | 1.3601 | 1.0770 | MN20160310_N01 | I15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 59.42 | 21.74 | 1497 | 6125 | 0.2444 | 0.6821 | MN20160310_N01 | M03 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 59.42 | 21.74 | 6393 | 6125 | 1.0437 | 1.0105 | MN20160310_N01 | M03 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 62.39 | 21.74 | 32 | 6112 | 0.0052 | 0.0487 | MN20160310_N01 | I15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 62.39 | 21.74 | 8679 | 6112 | 1.4198 | 1.0881 | MN20160310_N01 | I15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 62.39 | 21.74 | 1263 | 6112 | 0.2066 | 0.6476 | MN20160310_N01 | M03 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 62.39 | 21.74 | 6716 | 6112 | 1.0987 | 1.0233 | MN20160310_N01 | M03 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 64.36 | 21.74 | 18 | 6191 | 0.0029 | -0.0229 | MN20160310_N01 | I15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 64.36 | 21.74 | 9139 | 6191 | 1.4762 | 1.0978 | MN20160310_N01 | I15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 64.36 | 21.74 | 948 | 6191 | 0.1531 | 0.5888 | MN20160310_N01 | M03 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 64.36 | 21.74 | 6973 | 6191 | 1.1263 | 1.0294 | MN20160310_N01 | M03 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 66.33 | 21.74 | 6 | 6235 | 0.0010 | -0.1459 | MN20160310_N01 | I15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 66.33 | 21.74 | 9360 | 6235 | 1.5011 | 1.1020 | MN20160310_N01 | I15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 66.33 | 21.74 | 710 | 6235 | 0.1139 | 0.5327 | MN20160310_N01 | M03 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 66.33 | 21.74 | 7238 | 6235 | 1.1608 | 1.0369 | MN20160310_N01 | M03 |